Foxp1 has been found to bind to the upstream region of the β-adrenergic receptor (β-AR) promoter, inhibiting its expression, controlling brown/beige adipocyte differentiation, and promoting the progression of bladder cancer [50, 51]. The gene discussed is FOXP1; the disease is urinary bladder carcinoma.